微信关注
China
Total item
Cart Subtotal
￥ 0.00 “ab fubinaca”的搜索结果
-
Rislenemdaz
Catalog No. A21907 NMDA receptor GluN2B antagonistRislenemdaz (CERC-301) is an orally bioavailable and selective N-methyl-D-aspartate (NMDA) receptor subunit 2B (GluN2B) antagonist with Ki and IC50 of 8.1 nM and 3.6 nM, respectively. 了解更多 -
Zabofloxacin hydrochloride
Catalog No. A21901 antibacterialZabofloxacin hydrochloride (DW-224a) is a novel fluoronaphthyridone quinolone that is considered a potent antibacterial candidate for clinical trials. 了解更多 -
L-Buthionine-(S,R)-sulfoximine
Catalog No. A21895 g-glutamylcysteine synthetase inhibitorL-Buthionine-(S,R)-sulfoximine is a cell-permeable, potent, fast acting and irreversible inhibitor of g-glutamylcysteine synthetase and depletes cellular glutathione levels. 了解更多 -
TAK-659 hydrochloride
Catalog No. A21885 Syk inhibitorTAK-659 hydrochloride is a potent, selective and orally available spleen tyrosine kinase (Syk) inhibitor with an IC50 of 3.2 nM. 了解更多 -
Febuxostat D9
Catalog No. A21882 xanthine oxidase inhibitorFebuxostat D9 is deuterium labeled Febuxostat, which is a selective xanthine oxidase inhibitor with Ki of 0.6 nM. 了解更多 -
Etoricoxib D4
Catalog No. A21877 COX-2 inhibitorEtoricoxib D4 (MK-0663 D4) is a deuterium labeled Etoricoxib. Etoricoxib is a non steroidal anti-inflammatory agent, acting as a selective and orally active COX-2 inhibitor, with IC50s of 1.1 μM and 116 μM for COX-2 and COX-1 in human whole blood. 了解更多 -
Vilazodone D8
Catalog No. A21876 SSR inhibitor / 5-HT1A receptor partial agonistVilazodone D8 is the a deuterium labeled vilazodone, which is a combined serotonin specific reuptake inhibitor (SSRI) and 5-HT1A receptor partial agonist. 了解更多 -
Tesevatinib
Catalog No. A21875 multi-target tyrosine kinase inhibitorTesevatinib (XL-647; EXEL-7647; KD-019) is an orally available, multi-target tyrosine kinase inhibitor; inhibits EGFR, ErbB2, KDR, Flt4 and EphB4 kinase with IC50s of 0.3, 16, 1.5, 8.7, and 1.4 nM. 了解更多 -
Fostamatinib disodium hexahydrate
Catalog No. A21873 Syk inhibitorFostamatinib disodium hexahydrate (R788 disodium hexahydrate), a prodrug of the active metabolite R406, is a potent Syk inhibitor with IC50 of 41 nM. 了解更多 -
Btk inhibitor 1 R enantiomer hydrochloride
Catalog No. A21865 BTK inhibitorBtk inhibitor 1 R enantiomer hydrochloride (Ibrutinib analog hydrochloride) (Compound 14) is a covalent and irreversible Bruton??s tyrosine kinase (BTK) inhibitor and can be used in synthesis of Ibrutinib and ibrutinib-based activity-based probes (ABPs). 了解更多 -
Btk inhibitor 1 (R enantiomer)
Catalog No. A21861 BTK inhibitorBtk inhibitor 1 R enantiomer (Ibrutinib analog) (Compound 14) is a covalent and irreversible Bruton??s tyrosine kinase (BTK) inhibitor and can be used in synthesis of Ibrutinib and ibrutinib-based activity-based probes (ABPs). 了解更多 -
Cediranib maleate
Catalog No. A21857 VEGFR inhibitorCediranib maleate (AZD-2171 maleate) is a highly potent, orally available VEGFR inhibitor with IC50s of <1, <3, 5, 5, 36, 2 nM for Flt1, KDR, Flt4, PDGFRα, PDGFRβ, c-Kit, respectively. 了解更多 -
AZD5153 6-Hydroxy-2-naphthoic acid
Catalog No. A21852 BET/BRD4 bromodomain inhibitorAZD5153 6-Hydroxy-2-naphthoic acid is the 6-Hydroxy-2-naphthoic acid of AZD5153. AZD5153 is a potent, selective, and orally available BET/BRD4 bromodomain inhibitor; disrupts BRD4 with an IC50 of 1.7 nM. 了解更多 -
2-Keto Crizotinib
Catalog No. A21848 2-Keto Crizotinib (PF-06260182) is an active lactam metabolite of crizotinib. 了解更多 -
S107 hydrochloride
Catalog No. A21839 S107 hydrochloride is a RyR-selective 1,4-benzothiazepine derivative that stabilizes RyR2 channels by enhancing the binding affinity of calstabin2 to mutant and/or PKA-phosphorylated channels. 了解更多 -
Anandamide
Catalog No. A21835 immune modulatorAnandamide is an immune modulator in the central nervous system acts via not only cannabinoid receptors (CB1 and CB2) but also other targets (e.g., GPR18/GPR55). 了解更多 -
Zileuton sodium
Catalog No. A21831 5-lipoxygenase inhibitorZileuton sodium (A 64077 sodium) is a potent and selective inhibitor of 5-lipoxygenase, exhibiting inflammatory activities. 了解更多 -
CP-640186 hydrochloride
Catalog No. A21808 ACC inhibitorCP-640186 hydrochloride is a potent and cell-permeable Acetyl-CoA carboxylase (ACC) inhibitor with IC50s of 53 nM and 61 nM for rat liver ACC1 and rat skeletal muscle ACC2 respectively. 了解更多 -
Lumicitabine
Catalog No. A21807 RSV polymerase inhibitorLumicitabine (ALS-008176) is an inhibitor of the respiratory syncytial virus (RSV) polymerase. 了解更多 -
1-Naphthyl PP1 hydrochloride
Catalog No. A21790 Src/c-Abl inhibitor1-Naphthyl PP1 hydrochloride is a selective inhibitor of src family kinases v-Src and c-Fyn as well as the tyrosine kinase c-Abl (IC50 values are 1.0, 0.6, 0.6, 18 and 22 μM for v-Src, c-Fyn, c-Abl, CDK2 and CAMK II respectively). 了解更多 -
VP3.15 dihydrobromide
Catalog No. A21789 PDE7/GSK3 inhibitorVP3.15 dihydrobromide is a potent, orally bioavailable and CNS-penetrant dual phosphodiesterase (PDE)7- glycogen synthase kinase (GSK)3 inhibitor, with IC50s of 1.59 μM and 0.88 μM for PDE7 and GSK-3, respectively. 了解更多 -
PSI-6206 13CD3
Catalog No. A21782 HCV NS5B polymerase inhibitorPSI-6206 13CD3 is the deuterium labeled PSI-6206. PSI-6206 is the deaminated derivative of PSI-6130, which is a potent and selective inhibitor of HCV NS5B polymerase. 了解更多 -
SHP099 hydrochloride
Catalog No. A21762 SHP2 inhibitorSHP099 hydrochloride is a potent, selective and orally available SHP2 inhibitor with an IC50 of 70 nM. 了解更多 -
Tazemetostat hydrobromide
Catalog No. A21759 EZH2 inhibitorTazemetostat hydrobromide (EPZ-6438 hydrobromide) is a potent, selective and orally available EZH2 inhibitor. 了解更多 -
SSTR5 antagonist 2 TFA
Catalog No. A21752 SSTR5 antagonistSSTR5 Antagonist 1 (compound 10) is a highly potent, oral active and selective somatostatin (receptor) subtype 5 (SSTR5) antagonist and has potential to treat type 2 diabetes mellitus (T2DM). 了解更多 -
Aldosterone D8
Catalog No. A21740 Aldosterone D8 is a deuterium labeled Aldosterone. Aldosterone, produced in the adrenal zona glomerulosa, regulates blood pressure. 了解更多 -
Gaboxadol hydrochloride
Catalog No. A21730 GABAA receptors agonistGaboxadol hydrochloride (Lu 02-030 hydrochloride) is a selective agonist at GABAA receptors that contain α4-δ subunits, and has anxiolytic and sedative effects. 了解更多 -
Pyridostatin hydrochloride
Catalog No. A21727 G-quadruplexe stabilizerPyridostatin hydrochloride (RR82 hydrochloride) is a G-quadruplexe stabilizer, with a Kd of 490 nM. 了解更多 -
AZD9496 maleate
Catalog No. A21726 estrogen receptor (ERα) antagonistAZD9496 maleate is a potent and selective estrogen receptor (ERα) antagonist with IC50 of 0.28 nM. AZD9496 maleate is an orally bioavailable selective oestrogen receptor degrader (SERD). 了解更多 -
Galactose 1-phosphate Potassium salt
Catalog No. A21713 Galactose 1-phosphate Potassium salt is is an intermediate in the galactose metabolism and nucleotide sugars. 了解更多 -
Taranabant ((1R,2R)stereoisomer)
Catalog No. A21705 CB1 receptor inverse agonistTaranabant (1R,2R)stereoisomer is the R-enantiomer of Taranabant. Taranabant is a highly potent and selective cannabinoid 1 (CB1) receptor inverse agonist. 了解更多 -
BMS-654457
Catalog No. A21704 Factor XIa (FXIa) inhibitorBMS-654457 is a small-molecule, reversible inhibitor of factor XIa (FXIa), binding with human and rabbit FXIa with Kis of 0.2 and 0.42 nM, respectively. 了解更多 -
TAK-960 hydrochloride
Catalog No. A21703 PLK1 inhibitorTAK-960 hydrochloride is an orally available, selective inhibitor of polo-like kinase 1 (PLK1), with an IC50 of 0.8 nM at 10 μM ATP; TAK-960 hydrochloride also shows inhibitory activities against PLK2 and PLK3, with IC50s of 16.9 and 50.2 nM, respectively. 了解更多 -
(1S,2S,3R)-DT-061
Catalog No. A21701 PP2A activator(1S,2S,3R)-DT-061 is an enantiomer of DT-061. DT-061 is an orally bioavailable activator of protein phosphatase 2A (PP2A) and could be applied in the therapy of KRAS-mutant and MYC-driven tumorigenesis. 了解更多 -
Taranabant racemate
Catalog No. A21699 CB1 antagonist/inverse agonistTaranabant racemate is an antagonist and/or inverse agonist of the Cannabinoid-1 (CB1) receptor extracted from patent WO 2004048317 A1. 了解更多 -
diABZI STING agonist-1 trihydrochloride
Catalog No. A21694 STING receptor agonistdiABZI STING agonist-1 (trihydrochloride) is a selective stimulator of interferon genes (STING) receptor agonist, with an EC50s of 130 for human PBMCs. 了解更多 -
diABZI STING agonist-1
Catalog No. A21688 STING receptor agonistdiABZI STING agonist-1 is a selective stimulator of interferon genes (STING) receptor agonist, with an EC50s of 130 nM for human PBMCs. 了解更多 -
Val-cit-PAB-OH
Catalog No. A21686 -
3-Methoxytyramine
Catalog No. A21676 neuromodulator3-Methoxytyramine, a well known extracellular metabolite of 3-hydroxytyramine/dopamine, is a neuromodulator. 了解更多 -
BMS-599626
Catalog No. A21664 HER1/HER2 inhibitorBMS-599626 (AC480) is a selective and orally bioavailable HER1 and HER2 inhibitor, with IC50s of 20 and 30 nM, respectively. 了解更多 -
HS-10296 hydrochloride
Catalog No. A21661 EGFR/T790M inhibitorHS-10296 hydrochloride is an orally available and third-Generation inhibitor of epidermal growth factor receptor (EGFR)-activating mutations and T790M-resistant mutation with limited activity against wild-type EGFR. 了解更多 -
l-Atabrine dihydrochloride
Catalog No. A21646 l-Atabrine dihydrochloride is a less active enantiomer of quinacrine which displays antiprion activity. 了解更多 -
Albendazole sulfoxide D3
Catalog No. A21640 Albendazole sulfoxide D3 is deuterium labeled Albendazole sulfoxide, which is a broad-spectrum anthelmintic. 了解更多
联系我们
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
Not your Region? View all Distributors
FILTER BY:
购物选项
- 分类
-
- Epigenetics (40)
- Apoptosis (13)
- PI3K / Akt / mTOR (12)
- Protein Tyrosine Kinases (34)
- Angiogenesis (64)
- MAPK (7)
- JAK / Stat (10)
- Cell Cycle (15)
- DNA Damage (27)
- Cytoskeleton (9)
- Cell Metabolism (56)
- Autophagy Signaling (3)
- Immunology & Inflammation (12)
- GPCR / G Protein (67)
- NF-kB/IkB (6)
- Neuronal Signaling (69)
- Proteases (27)
- Microbiology (23)
- Stem Cells / Wnt (9)
- Membrane Transporters/Ion Channels (26)
- Endocrinology / Hormones (12)
- Ubiquitin (1)
- PROTACs (2)
- Others (29)
- Natural Products (11)
- Ready to Use Solution (65)
- Products On Sale (106)
- Recombinant Proteins (88)
- Polyclonal Antibodies (29)
- Growth Factors (11)
- Hormones (3)
- Monoclonal Antibodies (14)
- Viral Antigens (12)
- Chemokines (1)
- Cytokines (1)
- Enzymes (15)
- COVID-19 Related Products (1)
- 作用机制
-
- Inhibitor (抑制剂) (366)
- Agonist (激动剂) (76)
- Antagonist (拮抗剂) (66)
- Activator (激活剂) (9)
- Modulator (调节剂) (25)
- Blocker (阻断剂) (6)
- Degrader (降解剂) (3)
- Inducer (诱导剂) (2)
- Stabilizer (稳定剂) (9)
- Stimulator (刺激物) (1)
- Potentiator (增强剂) (2)
- 靶点
-
- Abl (6)
- Aurora A (4)
- Aurora B (2)
- Aurora C (1)
- B-Raf (2)
- Bcl-2 (4)
- Bcl-B (1)
- Bcl-w (4)
- Bcl-xL (5)
- BCL2A1 (1)
- Bcr-Abl (1)
- BRD2 (1)
- C-Raf (Raf-1) (3)
- CDK4 (1)
- DNMT (2)
- EphB4 (1)
- FGFR1 (6)
- FGFR2 (2)
- FGFR3 (2)
- FLT3 (1)
- HDAC (1)
- HDAC1 (2)
- HDAC10 (1)
- HDAC2 (1)
- HDAC3 (1)
- HDAC4 (1)
- IGF1R (1)
- JAK2 (2)
- KAT5 (Tip60) (1)
- Kit (2)
- Mcl-1 (2)
- MEK1 (1)
- MEK2 (1)
- p53 (3)
- PARP (2)
- PDGFRα (2)
- PDGFRβ (2)
- RET (2)
- Src (4)
- TrkA (1)
- VEGFR1 (FLT1) (1)
- VEGFR2 (FLK1) (3)
- VEGFR3 (FLT4) (1)
ADOOQ 产品质量保证
We promise all products to perform as described.